PBM, CMPS, ATAI: Psychedelic Biotech Stocks Soar after White House Order for Faster FDA Reviews
TipRanks (Mon, 20-Apr 10:24 AM ET)
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
Benzinga (Mon, 20-Apr 10:08 AM ET)
Business Wire (Fri, 17-Apr 6:28 PM ET)
Enveric Biosciences targets up to $13.9M in total proceeds via share and warrant offering
Seeking Alpha News (Fri, 17-Apr 2:39 AM ET)
Business Wire (Thu, 16-Apr 8:00 PM ET)
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates
Business Wire (Tue, 31-Mar 8:00 AM ET)
Business Wire (Fri, 27-Mar 5:40 PM ET)
Enveric Biosciences Announces Registration of Five Trademarks
Business Wire (Wed, 18-Mar 8:00 AM ET)
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
Business Wire (Wed, 25-Feb 8:00 AM ET)
Market Chameleon (Thu, 19-Feb 3:21 AM ET)
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Enveric Biosciences trades on the NASDAQ stock market under the symbol ENVB.
As of April 20, 2026, ENVB stock price climbed to $4.75 with 46,098,229 million shares trading.
ENVB has a beta of 0.78, meaning it tends to be less sensitive to market movements. ENVB has a correlation of 0.01 to the broad based SPY ETF.
ENVB has a market cap of $6.60 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ENVB traded as high as $1,256.40 and as low as $1.71.
The top ETF exchange traded funds that ENVB belongs to (by Net Assets): PSIL.
ENVB has underperformed the market in the last year with a return of -66.2%, while SPY returned +36.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ENVB shares. However, ENVB has outperformed the market in the last 3 month and 2 week periods, returning +21.2% and +134.0%, while SPY returned +2.8% and +8.1%, respectively. This indicates ENVB has been having a stronger performance recently.
ENVB support price is $1.70 and resistance is $1.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENVB shares will trade within this expected range on the day.
